Compared to patients using drugs like insulin, metformin and even other medicines in the same GLP-1 drug class as semaglutide, and accounting for factors like age, sex and other health conditions, the researchers found patients using Ozempic were less likely to be diagnosed with TUD, as well as less likely to receive smoking cessation counseling or be prescribed medications to help them quit
Retatrutide Phase 2 Obesity Trial Investigators
References Department of Dermatology, Maulana Azad Medical College, & Lok Nayak Hospital, New Delhi College of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China SKINNOCENCE: The Skin Clinic & Research Centre, Gurugram, India Preeti Savardekar, Consultant Dermatologist, Mumbai, India Dipartimento di Farmacia, Universit degli Studi di Salerno, Via Giovanni Paolo II n
Hunter SJ, Garvey WT